Aptar Pharma

About Aptar Pharma

When Pharmaceutical companies around the world want to develop safe, efficient, and compliant medicines, they turn to Aptar Pharma – the go-to drug delivery expert, from formulation to patient – for proven drug delivery solutions and services. 

With over 75 years of proven experience, Aptar Pharma provides innovative drug delivery systems, components and active material solutions across the widest range of delivery routes including nasal, inhalation, ophthalmic, dermal and injectables. Aptar Pharma Services offers early stage to commercialization support to accelerate and derisk the drug development journey. With a strong focus on innovation, we are leading the way in developing digital healthcare solutions to help improve patient adherence and treatment experience. With a global manufacturing footprint of 15 manufacturing sites, Aptar Pharma provides security-of-supply and local support to customers. Aptar Pharma is part of AptarGroup, Inc. (NYSE: ATR). www.aptar.com/pharma

Categories
  • FR
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Pharmapack Europe 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025

Products from Aptar Pharma (50)

  • PremiumCoat®  ETFE Film Components

    Product PremiumCoat® ETFE Film Components

    Aptar Pharma's PremiumCoat® offers state-of-the-art ETFE-coated stoppers and plungers, combining superior container closure integrity and compatibility. With its highest standard specifications, it ensures optimal particulate protection for sensitive drugs.
  • UniDose (UDS) System

    Product UniDose (UDS) System

    Aptar Pharma's Unidose systems are nasal drug delivery devices for both liquid and powder forms, enabling precise single-dose delivery without healthcare professional intervention.
  • Nasal Vaccines

    Product Nasal Vaccines

    Aptar Pharma offers nasal vaccine solutions, suitable for liquid and powder formulations, that ensure precise dosing and ease of use for healthcare professionals. These non-injectable alternatives potentially decrease cold chain storage needs, enhancing distribution.
  • Bidose (BDS) System

    Product Bidose (BDS) System

    Aptar Pharma's Bidose (BDS) is a two-shot, user-friendly nasal delivery device for liquid drugs. This sturdy, self-priming system permits accurate, one-handed operation, enabling non-invasive, systemic drug delivery without the assistance of a healthcare professional.
  • Breath Actuated Inhaler

    Product Breath Actuated Inhaler

    Aptar Pharma’s BAI is a user-friendly, breath-activated pMDI, that enhances adherence across all patient types, including children and the elderly. Suitable even for those with low inspiration rates, it ensures consistent dosage by delivering each dose upon inhalation at the mouthpiece. 
  • e-Dose Counter

    Product e-Dose Counter

    e-Dose Counter

    Aptar Pharma's e-Dose Counter technology, designed for user-friendliness, reliability, and accuracy, aims to enhance asthma and COPD patient compliance.
  • Activ-Blister Solutions

    Product Activ-Blister Solutions

    Activ- Blister

    Activ-Blister™ Solutions optimize product stability, shelf life, and consumer convenience by controlling the internal atmosphere of each blister cavity. They protect moisture and oxygen-sensitive oral solid doses and dry powder inhalation capsules.
  • Airless Drug Delivery Systems

    Product Airless Drug Delivery Systems

    Airless+

     
    Aptar Pharma's Airless+ Drug Delivery Systems deliver an airtight solution for dispensing sensitive dermal formulations, offering a vast range that includes more than 50 global Pharma
  • Bag-on-Valve Technology Platform

    Product Bag-on-Valve Technology Platform

    Aptar Pharma's Bag-on-Valve (BOV) Technology ensures safe, consistent aerosol dispensing with a variety of applications. It accommodates diverse flow rates and formulations without priming and is prized for its 360° functionality and precise dispensing control.
  • Ophthalmic Squeeze Dispensers Technology Platform

    Product Ophthalmic Squeeze Dispensers Technology Platform

    The Ophthalmic Squeeze Dispenser (OSD) is a leading preservative-free multidose eye dropper worldwide. It eliminates the need for preservatives and additives with its purely mechanical Tip-Seal technology. 
  • CPS Technology Platform

    Product CPS Technology Platform

    Aptar Pharma's CPS spray pump offers precise, reliable, and targeted preservative-free nasal drug delivery.
  • Prohaler®

    Product Prohaler®

    Aptar Pharma's Prohaler® is a patient-centric, high-performance DPI that ensures optimal patient compliance in treating asthma, COPD, and other pulmonary conditions.

Aptar Pharma Resources (3)

  • Webinar Advanced Parenteral Closure Solutions, The Perfect Fit Towards Compliance With EMA GMP Annex 1 Revision

    The revision of the European Medical Agency annex 1 of the GMP poses new challenges for Pharma manufacturers who have to implement a contamination control and sterility assurance strategies. Aptar Pharma Injectables’ Advanced Solutions perfectly combine to support our Pharma partners in tackling these new stringent requirements: PremiumFill®: Enhanced manufacturing means designed to deliver higher quality products with improved specifications, especially on contamination criteria, to boost your Contamination Control Strategy RTP bags: the new standard for avoiding contamination on aseptic filling lines, highly recommended in the Annex 1 revision Ready-to-Use Gamma: the only 100% guarantee of sterility at the time of use as requested in the Annex 1 revision
  • Webinar Mission Possible – Sustainability in Pharmaceutical Primary Packaging

    "Globally circularity is on top of consumers’ minds, and this is no different when it comes to pharmaceutical packaging. Hence, plastic materials are increasingly under scrutiny. For drug delivery systems, regulatory demand for patient safety strongly limits the use of mechanically recycled materials, and alternatives are required that make drug packaging more circular. Aptar Pharma’s Futurity™ platform of sustainable drug delivery solutions enhances circularity in pharmaceutical packaging, without compromising on performance and safety. Following the recent launch of APF Futurity™, the first metal-free, highly recyclable nasal spray pump, we are expanding our range adding the fully-recyclable Micro+ Futurity™ for dermal drug application. Created from monomaterial polyethylene, Micro+ Futurity™ leverages the user convenience and medical grade material selection of Aptar Pharma’s Airless+ dispensing solutions.
    Join Aptar Pharma’s session to learn how our Futurity™ platform can strengthen your circular approach with innovative drug dispensing solutions.